Thomas Gayner - Markel Group Inc.
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2018 Q1 | 10,000 | 0.01 | $63.20 | $632,000 | SEC | ||
| 2017 Q4 | 10,000 | 0.01 | $61.30 | $613,000 | SEC | ||
| 2017 Q3 | 10,000 | 0.01 | $63.70 | $637,000 | SEC | ||
| 2017 Q2 | 10,000 | 0.01 | $55.70 | $557,000 | SEC | ||
| 2017 Q1 | 10,000 | 0.01 | $54.40 | $544,000 | SEC | ||
| 2016 Q4 | 10,000 | 0.01 | $58.40 | $584,000 | SEC | ||
| 2016 Q3 | 10,000 | 0.01 | $53.90 | $539,000 | SEC | ||
| 2016 Q2 | 10,000 | 0.02 | $73.50 | $735,000 | SEC | ||
| 2016 Q1 | 10,000 | 0.02 | $63.90 | $639,000 | SEC | ||
| 2015 Q4 | 10,000 | 0.02 | Buy | 0.02 | $68.80 | $688,000 | SEC |